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Abstract 
Herein, we report a new prebiotically plausible pathway towards a pyrimidine nucleobase in 
continuous manner. The route involves simultaneous methylation and carbamoylation of 
cyanoacetylene-derived ,-unsaturated thioamide with N-methyl-N-nitrosourea (MNU) in aqueous 
media. This provides S-methylpyrimidinone in one-pot, which can be converted into a variety of 4-
substituted pyrimidine nucleobases including cytosine and uracil. 
 
Main Text 
Elucidating the chemical process that gave birth to biologically essential molecules on the early 
Earth is key for understanding the origin of life. Among the major biomolecules, RNA is thought 
to have played a central role during chemical evolution. RNA can store genetic information and 
at the same time has the potential to catalyse chemical reactions.1–3 Therefore, RNA might be 
able to establish self-replicating systems amenable to Darwinian evolution.4,5 The essential 
components of RNA are purine (A, G) and pyrimidine (U, C) nucleobases, which form Watson-
Crick H-bonds. H-bonding and -stacking allows RNA to fold into complex shapes and modified 
nucleobases that are also part of contemporary RNA provide functionality far beyond what is 
observed with DNA.6 This structural diversity raise the question of how the constituting RNA 
nucleobases could have emerged. Did the chemical reactions that occurred on the early Earth 
provide only the canonical nucleosides, or were a plethora of different structures created, 
followed by a chemical evolution process that led to the selection of the fittest molecules for 
information encoding? An important additional feature of the pyrimidine and purine 
heterocycles is that they may be capable of providing a chiral field via dehydrated crystals7,8 
that could have played a role in the emergence of chirality. Finally, they can stabilize aggregates 
of amphiphiles and as such they could have been involved in forming cell-like vesicle 
surrounded by amphiphilic membranes.9 All these properties make research about the 
chemical origin of the pyrimidine and purine heterocycles a pressing problem. 
In pioneering work, Ferris et al. demonstrated cytosine formation from urea or sodium cyanate 
and cyanoacetylene.10 Miller et al. reported cytosine synthesis by heating a saturated solution 
  
of urea with cyanoacetaldehyde.11 The high reactivity of these cyano-derivatives, however, 
brings into question their accumulation to significant concentrations.12,13 Alternatively, 
pyrimidine nucleobases can also be generated from formamide under high energy conditions 
(e.g. heat, spark discharges) in the presence of meteorite or mineral powder.14,15 These 
conditions, however, may be too harsh for complex chemical systems that may have given rise 
to RNA. 
Fig. 1. (a) Previously reported pathway for pyrimidine nucleobase synthesis10,11 and (b) proposed 
pathway in this study.  
  
 
Here we report a new prebiotically plausible pathway to pyrimidines, which takes place in 
water. We discovered that cyanoacetylene 1 (Fig. 1) reacts quickly with dimethylamine. Both 
compounds were likely present on the early Earth. The reaction provides the stable acrylonitrile 
derivative 2, in which the reactivity of cyanoacetylene is captured. 2 is subsequently converted 
into a stable ,-unsaturated thioamide 3 upon sulfurization. Simultaneous methylation and 
carbamoylation of 3 gives carbamoylimidothioate 4, with spontaneous cyclization to the S-
methylpyrimidinones (SMePy, 6) under basic conditions. Simultaneous methylation and 
carbamoylation under prebiotically plausible conditions is achieved with N-methyl-N-
nitrosourea (MNU, 5).16  
 
Table 1. Yields obtained under different reaction conditions for the conversion of 1 to 3. a Yields were 
determined by HPLC. 
 
 
We first investigated the synthesis of ,-unsaturated thioamide 3 from cyanoacetylene 1 
under prebiotically plausible conditions. Due to the electron-withdrawing nature of the nitrile 
group, the alkyne moiety of cyanoacetylene 1 is highly susceptible to a nucleophilic addition at 
its alkyne terminus.  Indeed, upon addition to aqueous dimethylamine solution, 1 reacted 
immediately and quantitatively to form 3-(dimethylamino)acrylonitrile 2 (Scheme S1). 
Compound 2 was subsequently subjected to sulfurization. In initial attempts, we tested 
solutions of sodium hydrogen sulphide in phosphate, borate or carbonate buffer with different 
pH as a model solution of hydrogen sulphide.17 These conditions, however, gave only trace 
amount of the desired ,-unsaturated thioamide 3 (data not shown). We next turned our 
attention to ammonium sulphide as a prebiotically relevant sulfurization reagent. Ammonium 
sulphide is a salt of ammonia and hydrogen sulphide, both plausible prebiotic molecules. 
Ammonium sulphide is for example found in the atmosphere of Titan and Jupiter.18,19 When 
the acrylonitrile derivative 2 was reacted with different concentrations of ammonium sulphide 
in water at 55°C, formation of the desired ,-unsaturated thioamide compound 3 was 
observed. Notably, it turned out that thioamide 3 (63%) crystallized out from the reaction 
mixture upon cooling to room temperature, which can be considered to be a naturally occuring 
enrichment step by temperature change.  
 
  
We next examined if 3 can be formed in one-pot, despite the presence of competing 
nucleophiles. Cyanoacetylene 1 was slowly added to the solution containing different 
equivalents of dimethylamine and ammonium sulphide, and the reaction was gently heated to 
55°C and analysed by reverse phase HPLC. The reaction provided thioamide 3 in high yields (up 
to 97%, Table 1) showing that 1 reacts selectively with dimethylamine followed by capturing of 
the intermediate with (NH4)2S. 
Table 2. Yields obtained under different reaction conditions for the conversion of 3 to 6. a Yields were 
determined by HPLC.  
 
 
We further investigated the reaction of the so formed thioamide 3 with MNU 5 for the 
formation of SMePy 6. MNU 5 can be synthesized under plausible prebiotic conditions by 
reacting N-methylurea with sodium nitrite in a slightly acidic environment. MNU 5 separates 
spontaneously from the water solution, allowing it to be locally available in high quantities. It 
is known that MNU produces diazomethane and isocyanic acid under basic conditions or by 
thermal degradation.20 Accordingly, we assumed that MNU would operate as a bifunctional 
reagent. We expected that the carbamoylimidothioate 4, which is formed by the methylation 
of thiocarbonyl group of thioamide 3 with diazomethane would undergo carbamoylation with 
isocyanic acid, followed by a base-catalysed cyclization to build up the pyrimidine skeleton. For 
this, MNU 5 was added to the solution containing thioamide 3 and sodium bicarbonate under 
mild heating at 55°C. The reaction was monitored by HPLC (Fig. S2a). The newly present peak 
was isolated and analysed by 1H-NMR, confirming formation of the desired SMePy 6. We did 
  
not observe the carbamoylimidothioate 4 in the HPLC chromatogram, presumably because it 
cyclizes immediately to SMePy 6 after the carbamoylation reaction. The yield of SMePy 6 was 
determined to be 22% by HPLC-MS based on the calibration curve that was prepared using a 
chemically synthesized reference compound.21 
The reaction was further investigated regarding its sensitivity to the presence of different prebiotically 
relevant bases and minerals. The data are summarized in Table 2 and Fig. S2. All tested conditions gave 
similar yields of SMePy 6, showing that the reaction is robust, which is one of our main criteria for 
calling a reaction prebiotically plausible. More importantly, formation of SMePy 6 was observed in the 
presence of the ammonium sulphide under conditions also utilized for the formation of thioamide 3. 
This observation led to the idea to conduct a one-pot synthesis of the SMePy 6, a precursor of canonical 
and non-canonical pyrimidine nucleobases.  
Figure 2. One-pot synthesis of SMePy 6 in the presence of different equivalents of the reagents. a Yields 
were determined by HPLC. 
 
To achieve a one-pot synthesis of 6 (Fig. 2), cyanoacetylene 1 was first reacted with a 
dimethylamine solution containing ammonium sulphide in different amounts. After warming 
the reaction to 55°C for 24 hrs, the reaction mixture was diluted with water and MNU 5 was 
added. The reaction mixture was again warmed to 55°C for another 24 hrs and finally analysed 
by reverse phase HPLC. The desired SMePy 6 was obtained in 14-17% yield over three steps 
under these one-pot conditions. 
Finally, we investigated the conversion of SMePy 6 to canonical nucleobases under plausible 
prebiotic conditions (Table 3). The conversion of SMePy 6 into uracil 7a can be catalysed by 
Fe2+. Heating SMePy 6 in aqueous solution containing FeSO4, provided 7a quantitatively. FeSO4 
is naturally available from minerals such as Rozenite and Melanterite.22 Cytosine 7b was in 
contrast obtained by heating SMePy 6 in aqueous ammonia solution in the presence of FeSO4. 
  
This demonstrates an efficient “mineral guided” formation of the canonical pyrimidine bases. 
Furthermore, reaction of 6 with ammonium sulphide furnished 4-thiouracil 7c, another well-
known modification present in the tRNA of bacteria and archaea.23 Interestingly, the 
concentration of ammonium sulphide determines the outcome of this reaction, while either 
cytosine or 4-thiouracil is formed (Table 3). Since cytosine hydrolysed slowly to uracil, the 
ammonium sulphide conditions provide cytosine, uracil and 4-thiouracil simultaneously. 
Finally, we investigated whether also non-canonical bases can form from SMePy 6. Such bases 
are present in contemporary RNA as constituents to modify structural and functional features.6 
If they would form under identical conditions, this would strengthen our hypothesis that 
canonical and non-canonical bases emerged  simultaneously as competitor and companion 
molecules that found their roles in a subsequent chemical selection process.16,17,24–26 In order 
to investigate this possibility we reacted SMePy 6 with different amines in aqueous solutions. 
Upon treatment with methylamine and dimethylamine, 4-mono- and 4-dimethylcytosine (7d 
and 7e) were obtained respectively, which are indeed found as modified bases in contemporary 
RNA species.27  
Table 3. Conversion yields of 6 to 4-substituted pyrimidines with different nucleophiles. a Isolated yield. 
b Yields were determined by HPLC. 
  
In summary, we discovered a new plausible prebiotic pathway, which takes place in continuous 
manner in water. The process provides canonical as well as C4-modified pyrimidine 
nucleobases. Although cyanoacetylene has been widely investigated as the building block of 
nucleobases and nucleosides, its high-electrophilic character has always questioned its 
involvement. Here we show that one can start the pyrimidine synthesis with a trapped version 
of cyanoacetylene, namely the stable acrylonitrile derivative. We show that the cascade 
reaction proceeds under one-pot conditions in a continuous manner to provide SMePy 6. 
Importantly the key intermediate SMePy 6 gives rise not only to canonical but also to non-
canonical bases arguing for the simultaneous prebiotic formation of a diverse set of pyrimidines 
under prebiotically plausible conditions.  
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1. General 
Chemicals were purchased from Sigma-Aldrich, TCI, Fluka, ABCR, Carbosynth or Acros organics 
and used further purification. The solvents were of reagent grade or purified by distillation. 
Reactions and chromatography fractions were monitored by qualitative thin-layer chromatography 
(TLC) on silica gel F254 TLC plates from Merck KGaA. Flash column chromatography was performed 
on Geduran® Si60 (40-63 μm) silica gel from Merck KGaA. NMR spectra were recorded on Bruker 
AVIIIHD 400 spectrometers (400 MHz). 1H NMR shifts were calibrated to the residual solvent 
resonances: CDCl3 (7.26 ppm), DMSO-d6 (2.50 ppm), CD3OD (4.87 ppm), D2O (4.79 ppm). 13C NMR 
shifts were calibrated to the residual solvent: CDCl3 (77.16 ppm), DMSO-d6 (39.52 ppm), CD3OD 
(49.00 ppm). All NMR spectra were analyzed using the program MestRE NOVA 10.0.1 from 
Mestrelab Research S. L. Normal resolved mass spectra were measured on a LTQ FT-ICR by Thermo 
Finnigan GmbH. High resolution mass spectra were measured by the analytical section of the 
Department of Chemistry of the Ludwigs-Maximilians-Universität München on the following 
spectrometers (ionization mode in brackets): MAT 95 (EI) and MAT 90 (ESI) from Thermo Finnigan 
GmbH. IR spectra were recorded on a PerkinElmer Spectrum BX II FT-IR system. All substances 
were directly applied as solids or on the ATR unit. Analytical RP-HPLC was performed on an 
analytical HPLC Waters Alliance (2695 Separation Module, 2996 Photodiode Array Detector) 
equipped with the column Nucleosil 120-2 C18 from Macherey Nagel using a flow of 0.5 ml/min, a 
gradient of 0-70% of buffer B in 30 min was applied for the measurements. Preparative RP-HPLC 
was performed on a HPLC Waters Breeze (2487 Dual λ Array Detector, 1525 Binary HPLC Pump) 
equipped with the column VP 250/32 C18 from Macherey Nagel. Using a flow of 5 ml/min, a gradient 
of 0-70% of buffer B in 30 min was applied for the purifications. Buffer A: 50 mM ammonium formate 
in H2O, Buffer B: 50 mM ammonium formate in 80% (v/v) acetonitrile. Detection wavelength: 260 
nm. 
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2. A stepwise synthesis of thioamide 3 under plausible prebiotic conditions 
 
 
Scheme S1.  A stepwise synthesis of thioamide 3 from cyanoacetylene 1 
 
3-(Dimethylamino)acrylonitrile (2) 
 
To a solution of dimethylamine (405 μl, 40% in H2O, 3.19 mmol) in H2O (16 ml) was added 
cyanoacetylene 1 (100 µl, 1.60 mmol) at room temperature. After 20 h, the colorless solution was 
extracted with CH2Cl2. The combined organic phase was washed with brine and dried over MgSO4. 
The solvent was removed under reduced pressure to yield the compound 2 (140 mg, 1.50 mmol, 94%) 
as a colorless oil. The spectra data matched with the compound 2 purchased from TCI Germany 
(product number: D2094). 
IR (neat, cm–1) 3077 (w), 2915 (w), 2818 (w), 2189 (s), 1623 (s), 1485 (w), 1437 (m), 1420 (w), 1391 (s), 
1346 (m), 1287 (m), 1214 (w), 1114 (m), 1066 (m), 1023 (w), 957 (m), 862 (w), 709 (m), 1H NMR (400 
MHz, DMSO-d6) δ 7.21 (d, J = 13.4 Hz, 1H), 3.82 (d, J = 13.5 Hz, 1H), 2.89 (br, 3H), 2.70 (br, 3H), 13C 
NMR (100 MHz, DMSO-d6) δ 155.1, 122.7, 58.3, HRMS (EI) calcd. for C5H8N2+ [M]+: 96.0687, found: 
96.0683. 
 
3-(Dimethylamino)prop-2-enethioamide (3) 
 
To a solution of (NH4)2S (20 ml, 20% in H2O,  mmol) in H2O (20 ml) was added compound 2 (2 ml, 
19.76  mmol), and the reaction mixture was stirred at 55°C. After 12 h, the reaction mixture was 
cooled to room temperature. The compound 3 crystallized out from the reaction mixture as a yellow 
solid (1.63 g, 12.51 mmol, 63%).  
IR (neat, cm–1) 3337 (w), 3268 (w), 3158 (m), 1600 (s), 1495 (w), 1428 (m), 1372 (m), 1342 (m), 1310 
(m), 1278 (s), 1114 (s), 1038 (s), 980 (s), 861 (s), 810 (s), 670 (m), 1H NMR (400 MHz, DMSO-d6) δ 8.01 
(br, 1H), 7.86 (br, 1H), 7.70 (d, J = 12.2 Hz, 1H), 5.20 (d, J = 12.2 Hz, 1H), 2.88 (s, 6H), 13C NMR (100 
MHz, DMSO-d6) δ 194.6, 155.3, 96.5, HRMS (EI) calcd. for C5H10N2S+ [M]+: 130.0565, found: 
130.0560. 
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3. One-pot synthesis of thioamide 3 under plausible prebiotic conditions 
 
 
Cyanoacetylene 1 (20 μl, 0.32 mmol) was added to a solution of dimethylamine (40% in H2O, 2 or 
5 eq.) and ammonium sulfide (20% in H2O, 5 or 10 eq.) in H2O (2 ml) at room temperature, and the 
reaction mixture was shaken at 55°C for 24 h in a thermomixer. The reaction was monitored by 
HPLC (Fig. S1). The product peak (compound 3; Retention time: 12.8 min) was isolated and analyzed 
by NMR measurement by which the structural integrity was confirmed. The yield of the compound 3 
from each reaction was determined according to the calibration curve prepared from the 
synthetically prepared compound 3 (Fig. S5a).(1) 
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Figure S1.  HPLC analysis of the one-pot thioamide 3 syntheses in different equivalents of the reagents. 
(a) HNMe2 (2 eq.), (NH4)2S (5 eq.) (b) HNMe2 (2 eq.), (NH4)2S (10 eq.) 
(c) HNMe2 (5 eq.), (NH4)2S (5 eq.) (d) HNMe2 (5 eq.), (NH4)2S (10 eq.) 
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4. Synthesis of SMePy 6 under plausible prebiotic conditions 
 
To a solution of compound 3 (2 mg, mmol) in H2O (1 ml) was added base (1~10 eq.) and 
N-methyl-N-nitrosourea 5(2) (25 or 50 eq.), and the reaction mixture was shaken at 55°C for 24 h in a 
thermomixer. The reaction was monitored by HPLC (Fig. S2). The product peak (compound 6; 
Retention time: 13.2 min) was isolated and analyzed by NMR measurement by which the structural 
integrity was confirmed. The yield of the compound 6 from each reaction was determined according 
to the calibration curve prepared from the synthetically prepared compound 6 (Fig. S5b).(3) 
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Figure S2.  HPLC analysis of the SMePy 6 syntheses in the presence of different kinds of bases. 
(a) NaHCO3 (10 eq.), 5 (25 eq.) (b) NaHCO3 (10 eq.), 5 (50 eq.) 
(c) Borax (1 eq.), 5 (25 eq.) (d) Borax (1 eq.), 5 (50 eq.) 
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Figure S2 (continued).  HPLC analysis of the SMePy 6 syntheses in the presence of different kinds of bases. 
(e) (NH4)2S (3 eq.), 5 (25 eq.) (f) (NH4)2S (3 eq.), 5 (50 eq.) 
(g) Na2HPO4 (10 eq.), 5 (25 eq.) (h) Na2HPO4 (10 eq.), 5 (50 eq.) 
(i) CaCO3 (5 eq.), 5 (25 eq.) (j) CaCO3 (5 eq.), 5 (50 eq.) 
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5. One-pot synthesis of SMePy 6 under plausible prebiotic conditions 
 
Cyanoacetylene (20 μl, 0.32 mmol) was added to a solution of dimethylamine (40% in H2O, 2 or 5 
eq.) and ammonium sulfide (20% in H2O, 5 or 10 eq.) in H2O (2 ml) and samples were shaken at 55°C 
for 24 h. The solutions were made up to 16 ml with H2O to dissolve precipitate completely, and 1 ml of 
the solution was transferred into a new falcon tube. N-methyl-N-nitrosourea 5 (50 eq.) was added 
and the suspension was shaken at 55°C in a thermomixer for 24 h. The reaction was monitored by 
HPLC (Fig. S3). The yield of the compound 6 (Retention time: 13.2 min) from each reaction was 
determined according to the calibration curve (Fig. S5b). 
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Figure S3.  HPLC analysis of SMePy 6 syntheses in one-pot in different equivalents of the reagents. 
(a) HNMe2 (2 eq.), (NH4)2S (5 eq.) 
(c) HNMe2 (2 eq.), (NH4)2S (10 eq.) 
(b) HNMe2 (5 eq.), (NH4)2S (5 eq.) 
(d) HNMe2 (5 eq.), (NH4)2S (10 eq.) 
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6. Conversion of SMePy 6 into 4-substituted pyrimidine nucleobases 
 
Uracil (7a) 
 
Compound 6 (10 mg, 70 μmol) was added to a solution of FeSO4-7H2O (19.6 mg, 70 μmol) in H2O 
(5 ml) and the reaction mixture was stirred at 80°C. After 3 days, the reaction mixture was 
lyophilized. Purification of the crude product by flash column chromatography (CH2Cl2:MeOH = 
90:10 to 80:20) yielded compound 7a (7.8 mg, 69 μmol, quant.) as a colorless solid. The analytical data 
matched those reported previously.(4) 
 
Cytosine (7b) 
 
Compound 6 (10 mg, 70 μmol) was added to a solution of FeSO4-7H2O (19.6 mg, 70 μmol) in H2O 
(2.6 ml) and ammonia solution (28% in H2O, 1.7 ml) and the reaction mixture was stirred at 80°C. 
After 3 days, the reaction mixture was freeze dried. Purification of the crude product by flash column 
chromatography (CH2Cl2:MeOH = 90:10 to 50:50) yielded compound 7b (6.0 mg, 54 μmol, 77%) as a 
white foam. The analytical data matched those reported previously.(5) 
 
Cytosine (7b) and 4-thiouracil (7c) 
 
A solution of the compound 6 (0.8  μmol) in (NH4)2S (1 ml, 1, 5 or 10%) was stirred at 70°C for 16 h. 
The reaction was monitored by HPLC (Fig. S4a-c). The product peaks (compound 7b; Retention time: 
7.0 min, compound 7c; Retention time: 10.7 min) were isolated and analyzed by NMR measurement 
by which their structural integrity was confirmed. The analytical data matched those reported 
previously.(5),(6) The yields of the compound 7b and 7c from each reaction were determined according 
to the calibration curves (Fig. S5c, d). 
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4-Methylcytosine (7d) 
 
A solution of compound 6 (2 mg, 14.1  μmol) and methylamine (40% in H2O, 20 eq.) in H2O (1 ml) 
was stirred at 70°C for 36 h. The reaction was monitored by HPLC (Fig. S4d). The product peak 
(compound 7d; Retention time: 9.6 min) was isolated and analyzed by NMR measurement by which 
the structural integrity was confirmed. The yield of the compound 7d was determined according to 
the calibration curves (Fig. S5e). 
IR (neat, cm–1) 2815 (w), 1620 (s), 1536 (m), 1516 (m), 1416 (m), 1396 (m), 1380 (m), 1312 (m), 1237 
(w), 1175 (w), 1175 (w), 1125 (w), 1064 (w), 1016 (w), 970 (w), 924 (m), 788 (m), 775 (m), 729 (m), 1H 
NMR (400 MHz, DMSO-d6) δ 10.21 (s, 1H), 7.55 - 7.49 (m, 1H), 7.24 (d, J = 7.0 Hz, 1H), 5.56 (d, J = 
7.1 Hz, 1H), 2.73 (d, J = 4.7 Hz, 3H), 13C NMR (100 MHz, DMSO-d6) δ 165.4, 157.2, 141.6, 93.7, 27.2, 
HRMS (ESI) calcd. for C5H8N3O+ [M+H]+: 126.0662, found: 126.0662.  
 
4,4-Dimethylcytosine (7e) 
 
A solution of compound 6 (2 mg, 14.1  μmol) and dimethylamine (40% in H2O, 20 eq.) in H2O (1 
ml) was stirred at 70°C for 36 h. The reaction was monitored by HPLC (Fig. S4e). The product peak 
(compound 7e; Retention time: 11.6 min) was isolated and analyzed by NMR measurement by which 
the structural integrity was confirmed. The yield of the compound 7e was determined according to 
the calibration curves (Fig. S5f). 
IR (neat, cm–1) 3269 (w), 3126 (w), 3046 (m), 1656 (s), 1629 (s), 1604 (s), 1569 (s), 1536 (m), 1471 (m), 
1426 (s), 1397 (s), 1340 (s), 1293 (m), 1226 (s), 1153 (m), 1083 (m), 1003 (w), 956 (w), 878 (m), 816 (s), 
786 (s), 772 (m), 750 (m), 712 (m), 1H NMR (400 MHz, DMSO-d6) δ 10.43 (br, 1H), 7.40 (d, J = 7.4 Hz, 
1H), 5.87 (d, J = 7.3 Hz, 1H), 3.01 (br, 6H), 13C NMR (100 MHz, DMSO-d6) δ 164.8, 156.4, 143.2, 90.3, 
HRMS (ESI) calcd. for C6H10N3O+ [M+H]+: 140.0818, found: 140.0818. 
 
 
 
 
 
10 
 
 
 
 
0 5 10 15 20 25
0,000
0,002
0,004
0,006
0,008
0,010
0,012
0,014
m
A
U
time [min]
0 5 10 15 20 25
0,00
0,05
0,10
0,15
0,20
m
A
U
time [min]
0 5 10 15 20 25
-0,05
0,00
0,05
0,10
0,15
0,20
0,25
0,30
0,35
0,40
m
A
U
time [min]  
 
 
0 5 10 15 20 25
0,00
0,05
0,10
0,15
0,20
0,25
0,30
m
A
U
time [min]
0 5 10 15 20 25
0,00
0,05
0,10
0,15
0,20
0,25
0,30
m
A
U
time [min]  
Figure S4.  HPLC analysis of 4-substituted pyrimidine syntheses. 
 
(a) 1% (NH4)2S (b) 5% (NH4)2S (c) 10% (NH4)2S 
(d) 20 eq. H2NMe (e) 20 eq. HNMe2 
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7. Calibration curves of the compounds synthesized in this study 
To determine the concentration of a compound by HPLC a solution of the respective compound 
with a known concentration was made three times. The integrals and the arithmetic middle were 
calculated, and the average area under the curve from three independent experiment was plotted 
against the concentration. A regression line was generated and its equation was extracted. 
 
(a) Thioamide 3 
 
 
(b) SMePy 6 
 
 
Figure S5.  Calibration curves of the compounds synthesized in this study. 
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(c) Cytosine 7b 
 
 
 
 
(d) 4-Thiouracil 7c 
 
 
 
Figure S5 (continued).  Calibration curves of the compounds synthesized in this study. 
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(e) 4-Methylcytosine 
 
 
 
 
(f) 4,4-Dimethylcytosine 
 
 
 
Figure S5 (continued).  Calibration curves of the compounds synthesized in this study. 
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8. 1H and 13C NMR spectra of the compounds 
1H NMR and 13C NMR of the compound 2  
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1H NMR and 13C NMR of the compound 3  
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1H NMR and 13C NMR of the compound 6  
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1H NMR and 13C NMR of the compound 7d 
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1H NMR and 13C NMR of the compound 7e 
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9. HRMS spectra of compound 2 and 3  
 
HRMS (EI+) spectrum of compound 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HRMS (EI+) spectrum of compound 3 
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